Skip to main content
Top
Published in: Breast Cancer 4/2015

01-07-2015 | Original Article

What we should know in mammography after reduction mammoplasty and mastopexy?

Authors: Hanna Kim, Bong Joo Kang, Sung Hun Kim, Hyeon Sook Kim, Eun Suk Cha

Published in: Breast Cancer | Issue 4/2015

Login to get access

Abstract

Background

Reduction mammoplasty and mastopexy (breast lift surgery) are becoming increasingly common procedures. Knowledge of characteristic mammographic findings and imaging findings of breast cancer are important to interpret mammography in this population.

Methods

Patients undergoing a mammography examination between March 2006 and March 2012 were consecutively included. Seventy mammography examinations in 39 patients after reduction mammoplasty and 22 mammography examinations in 19 patients after mastopexy were reviewed and analyzed retrospectively. We compared the frequency of each characteristic mammographic finding between reduction mammoplasty and mastopexy. We also analyzed imaging findings of breast cancer in this population.

Results

The most frequent mammographic finding of the reduction mammoplasty was nipple elevation (84.3 %). Other findings included retraction of the lower breast (80 %), thickening of the skin (78.6 %), downward shifting of the glandular tissue (47.1 %), retroareolar fibrotic band (42.9 %), and areolar skin calcification or lipid cyst (35.7 %). The most frequent mammographic finding of mastopexy was thickening of the skin (72.7 %). Other mastopexy findings included elevation of nipple (68.2 %), areolar skin calcification or lipid cyst (36.4 %), retraction of lower position (31.8 %), and retroareolar fibrotic band (31.8 %). Downward shifting of glandular tissue and retraction of the lower portion have statistically lower frequency in mastopexy cases (P < 0.05). Two breast cancers were diagnosed in reduction mammoplasty cases. One was missed and one was detected but difficult to diagnose using mammography.

Conclusion

Although mammography alone is not sufficient for breast screening after reduction mammoplasty, it may be possible to use mammography for postoperative follow-up after mastopexy only. So, operators should recognize that after reduction mammoplasty it will be hard to detect early breast cancer.
Literature
1.
go back to reference Stevenson TR, Goldstein JA. TRAM flap breast reconstruction and contralateral reduction or mastopexy. Plast Reconstr Surg. 1993;92(2):228–33.PubMedCrossRef Stevenson TR, Goldstein JA. TRAM flap breast reconstruction and contralateral reduction or mastopexy. Plast Reconstr Surg. 1993;92(2):228–33.PubMedCrossRef
2.
go back to reference Hayes MK, Gold RH, Bassett LW. Mammographic findings after the removal of breast implants. AJR Am J Roentgenol. 1993;160(3):487–90.PubMedCrossRef Hayes MK, Gold RH, Bassett LW. Mammographic findings after the removal of breast implants. AJR Am J Roentgenol. 1993;160(3):487–90.PubMedCrossRef
3.
go back to reference Danikas D, Theodorou SJ, Kokkalis G, Vasiou K, Kyriakopoulou K. Mammographic findings following reduction mammoplasty. Aesthetic Plast Surg. 2001;25(4):283–5.PubMedCrossRef Danikas D, Theodorou SJ, Kokkalis G, Vasiou K, Kyriakopoulou K. Mammographic findings following reduction mammoplasty. Aesthetic Plast Surg. 2001;25(4):283–5.PubMedCrossRef
4.
go back to reference Muir TM, Tresham J, Fritschi L, Wylie E. Screening for breast cancer post reduction mammoplasty. Clin Radiol. 2010;65(3):198–205.PubMedCrossRef Muir TM, Tresham J, Fritschi L, Wylie E. Screening for breast cancer post reduction mammoplasty. Clin Radiol. 2010;65(3):198–205.PubMedCrossRef
5.
go back to reference Roberts JM, Clark CJ, Campbell MJ, Paige KT. Incidence of abnormal mammograms after reduction mammoplasty: implications for oncoplastic closure. Am J Surg. 2011;201(5):611–4.PubMedCrossRef Roberts JM, Clark CJ, Campbell MJ, Paige KT. Incidence of abnormal mammograms after reduction mammoplasty: implications for oncoplastic closure. Am J Surg. 2011;201(5):611–4.PubMedCrossRef
6.
go back to reference Uematsu T, Kasami M, Uchida Y. Soft-copy reading in digital mammography of microcalcifications: diagnostic performance of a 5-megapixel cathode ray tube monitor versus a 3-megapixel liquid crystal display monitor in a clinical setting. Acta Radiol. 2007;48(7):714–20.PubMedCrossRef Uematsu T, Kasami M, Uchida Y. Soft-copy reading in digital mammography of microcalcifications: diagnostic performance of a 5-megapixel cathode ray tube monitor versus a 3-megapixel liquid crystal display monitor in a clinical setting. Acta Radiol. 2007;48(7):714–20.PubMedCrossRef
7.
go back to reference American College of Radiology. Breast imaging reporting and data system, breast imaging atlas. 4th ed. Reston: American College of Radiology, 2003. American College of Radiology. Breast imaging reporting and data system, breast imaging atlas. 4th ed. Reston: American College of Radiology, 2003.
8.
go back to reference Miller CL, Feig SA, Fox JW. Mammographic changes after reduction mammoplasty. AJR Am J Roentgenol. 1987;149(1):35–8.PubMedCrossRef Miller CL, Feig SA, Fox JW. Mammographic changes after reduction mammoplasty. AJR Am J Roentgenol. 1987;149(1):35–8.PubMedCrossRef
9.
go back to reference Bae MS, Han W, Koo HR, Cho N, Chang JM, Yi A, et al. Characteristics of breast cancers detected by ultrasound screening in women with negative mammograms. Cancer Sci. 2011;102(10):1862–7.PubMedCrossRef Bae MS, Han W, Koo HR, Cho N, Chang JM, Yi A, et al. Characteristics of breast cancers detected by ultrasound screening in women with negative mammograms. Cancer Sci. 2011;102(10):1862–7.PubMedCrossRef
10.
go back to reference Lee JH, Kim EK, Oh JY, Kwon HC, Kim SH, Kim DC, et al. US screening for detection of nonpalpable locoregional recurrence after mastectomy. Eur J Radiol. 2013;82(3):485–9.PubMedCrossRef Lee JH, Kim EK, Oh JY, Kwon HC, Kim SH, Kim DC, et al. US screening for detection of nonpalpable locoregional recurrence after mastectomy. Eur J Radiol. 2013;82(3):485–9.PubMedCrossRef
11.
go back to reference Abboud M, Vadoud-Seyedi J, De Mey A, Cukierfajn M, Lejour M. Incidence of calcifications in the breast after surgical reduction and liposuction. Plast Reconstr Surg. 1995;96(3):620–6.PubMedCrossRef Abboud M, Vadoud-Seyedi J, De Mey A, Cukierfajn M, Lejour M. Incidence of calcifications in the breast after surgical reduction and liposuction. Plast Reconstr Surg. 1995;96(3):620–6.PubMedCrossRef
12.
go back to reference Robertson JL. Changed appearance of mammograms following breast reduction. Plast Reconstr Surg. 1977;59(3):347–51.PubMedCrossRef Robertson JL. Changed appearance of mammograms following breast reduction. Plast Reconstr Surg. 1977;59(3):347–51.PubMedCrossRef
13.
go back to reference Mitnick JS, Roses DF, Harris MN, Colen SR. Calcifications of the breast after reduction mammoplasty. Surg Gynecol. 1990;171(5):409–12. Mitnick JS, Roses DF, Harris MN, Colen SR. Calcifications of the breast after reduction mammoplasty. Surg Gynecol. 1990;171(5):409–12.
14.
go back to reference Sickles EA, Herzog KA. Mammography of the postsurgical breast. AJR Am J Roentgenol. 1981;136(3):585–8.PubMedCrossRef Sickles EA, Herzog KA. Mammography of the postsurgical breast. AJR Am J Roentgenol. 1981;136(3):585–8.PubMedCrossRef
15.
go back to reference Mandrekas AD, Assimakopoulos GI, Mastorakos DP, Pantzalis K. Fat necrosis following breast reduction. Br J Plast Surg. 1994;47(8):560–2.PubMedCrossRef Mandrekas AD, Assimakopoulos GI, Mastorakos DP, Pantzalis K. Fat necrosis following breast reduction. Br J Plast Surg. 1994;47(8):560–2.PubMedCrossRef
16.
go back to reference Miller JA, Festa S, Goldstein M. Benign fat necrosis simulating bilateral breast malignancy after reduction mammoplasty. South Med J. 1998;91(8):765–7.PubMedCrossRef Miller JA, Festa S, Goldstein M. Benign fat necrosis simulating bilateral breast malignancy after reduction mammoplasty. South Med J. 1998;91(8):765–7.PubMedCrossRef
17.
go back to reference Danikas D, Theodorou SJ, Kokkalis G, Vasiou K, Kyriakopoulou K. Mammographic findings following reduction mammoplasty. Aesthetic Plast Surg. 2001;25(4):283–5.PubMedCrossRef Danikas D, Theodorou SJ, Kokkalis G, Vasiou K, Kyriakopoulou K. Mammographic findings following reduction mammoplasty. Aesthetic Plast Surg. 2001;25(4):283–5.PubMedCrossRef
18.
go back to reference Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Bohm-Velez M, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299(18):2151–63.PubMedCentralPubMedCrossRef Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Bohm-Velez M, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299(18):2151–63.PubMedCentralPubMedCrossRef
19.
go back to reference Corsetti V, Houssami N, Ferrari A, Ghirardi M, Bellarosa S, Angelini O, et al. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer. 2008;44(4):539–44.PubMedCrossRef Corsetti V, Houssami N, Ferrari A, Ghirardi M, Bellarosa S, Angelini O, et al. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer. 2008;44(4):539–44.PubMedCrossRef
Metadata
Title
What we should know in mammography after reduction mammoplasty and mastopexy?
Authors
Hanna Kim
Bong Joo Kang
Sung Hun Kim
Hyeon Sook Kim
Eun Suk Cha
Publication date
01-07-2015
Publisher
Springer Japan
Published in
Breast Cancer / Issue 4/2015
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-013-0494-y

Other articles of this Issue 4/2015

Breast Cancer 4/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine